BMY vs JAKK · P/E 17, rev $24.46B vs P/E 4.9, rev $245.9M
Bristol-Myers Squibb Company (BMY) versus JAKKS Pacific Inc (JAKK) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
JAKKS Pacific Inc (JAKK) is a leisure company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported JAKK revenue for 2026-06-30 was $245.9M. Net income was $1.6M. JAKK currently screens at market cap $231.6M and trailing P/E 4.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. JAKK currently screens at market cap $231.6M and trailing P/E 4.9.
Not investment advice. Open the BMY and JAKK stock pages for the full models.
Not investment advice.